Evidence map›Paper›PMID 25887642›Full record

ArticleCritical care (London, England)2015

Propofol increases morbidity and mortality in a rat model of sepsis.

Martin Schläpfer, Tobias Piegeler, Randal O Dull, David E Schwartz, Mao Mao, Marcelo G Bonini, Birgit Roth Z'Graggen, Beatrice Beck-Schimmer, Richard D Minshall

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Risk of propofol use for sedation in COVID-19 patient.Anaesthesiology intensive therapy · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Martin SchläpferDepartment of Anesthesiology, University of Illinois at Chicago, 835 S Wolcott Ave (m/c 868), Chicago, IL, 60612, USA. martin.schlaepfer@uzh.ch.
Tobias PiegelerDepartment of Anesthesiology, University of Illinois at Chicago, 835 S Wolcott Ave (m/c 868), Chicago, IL, 60612, USA. tobias.piegeler@uzh.ch.
Randal O DullDepartment of Anesthesiology, University of Illinois at Chicago, 835 S Wolcott Ave (m/c 868), Chicago, IL, 60612, USA. rdull@uic.edu.
David E SchwartzDepartment of Anesthesiology, University of Illinois at Chicago, 835 S Wolcott Ave (m/c 868), Chicago, IL, 60612, USA. dschwarz@uic.edu.
Mao MaoDepartment of Pharmacology, University of Illinois at Chicago, Chicago, IL, USA. zeuchmao@gmail.com.
Marcelo G BoniniDepartment of Pharmacology, University of Illinois at Chicago, Chicago, IL, USA. mbonini@uic.edu.
Birgit Roth Z'GraggenInstitute of Physiology, Zurich Center for Integrative Human Physiology, University Zurich, Zurich, Switzerland. birgit.roth@fgcz.uzh.ch.
Beatrice Beck-SchimmerDepartment of Anesthesiology, University of Illinois at Chicago, 835 S Wolcott Ave (m/c 868), Chicago, IL, 60612, USA. beatrice.beckschimmer@uzh.ch.
Richard D MinshallDepartment of Anesthesiology, University of Illinois at Chicago, 835 S Wolcott Ave (m/c 868), Chicago, IL, 60612, USA. rminsh@uic.edu.
University of Illinois Chicago · USSwiss Integrative Center for Human Health · CHUniversity Hospital of Zurich · CH

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
New Strategies for Treating Septic Vasculopathy Inflammation and ThrombosisR01HL125356 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONINI, MARCELO G., DU, XIAOPING · 2014 to 2018
$3.4M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS R01 HL125356
6 · The paper itself

Abstract

introductionSevere sepsis is associated with approximately 50% mortality and accounts for tremendous healthcare costs. Most patients require ventilatory support and propofol is commonly used to sedate mechanically ventilated patients. Volatile anesthetics have been shown to attenuate inflammation in a variety of different settings. We therefore hypothesized that volatile anesthetic agents may offer beneficial immunomodulatory effects during the course of long-term intra-abdominal sepsis in rats under continuous sedation and ventilation for up to 24 hours.

methodsSham operation or cecal ligation and puncture (CLP) was performed in adult male Wistar rats followed by mechanical ventilation. Animals were sedated for 24 hours with propofol (7 to 20 mg/kg/h), sevoflurane, desflurane or isoflurane (0.7 minimal alveolar concentration each).

resultsSeptic animals sedated with propofol showed a mean survival time of 12 hours, whereas >56% of all animals in the volatile groups survived 24 hours (P <0.001). After 18 hours, base excess in propofol + CLP animals (-20.6 ± 2.0) was lower than in the volatile groups (isoflurane + CLP: -11.7 ± 4.2, sevoflurane + CLP: -11.8 ± 3.5, desflurane + CLP -14.2 ± 3.7; all P <0.03). Plasma endotoxin levels reached 2-fold higher levels in propofol + CLP compared to isoflurane + CLP animals at 12 hours (P <0.001). Also blood levels of inflammatory mediators (tumor necrosis factor-α, interleukin-1β, interleukin-10, CXCL-2, interferon-γ and high mobility group protein-1) were accentuated in propofol + CLP rats compared to the isoflurane + CLP group at the same time point (P <0.04).

conclusionsThis is the first study to assess prolonged effects of sepsis and long-term application of volatile sedatives compared to propofol on survival, cardiovascular, inflammatory and end organ parameters. Results indicate that volatile anesthetics dramatically improved survival and attenuate systemic inflammation as compared to propofol. The main mechanism responsible for adverse propofol effects could be an enhanced plasma endotoxin concentration, leading to profound hypotension, which was unresponsive to fluid resuscitation.

Indexed as

Respiration, ArtificialAnesthetics, IntravenousAnimalsDisease Models, AnimalMalePropofolRatsRats, WistarSepsisAnesthetics, IntravenousPropofol

Identifiers

PMID25887642
PMCPMC4344774
OpenAlexW2064014695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.